May 2, 2025 Overview On January 15, 2025, DuPont de Nemours, Inc. ("DuPont", or after the completion of the Intended Electronics Separation, "New DuPont") announced it is targeting November 1, 2025 to complete the intended separation of its Electronics business (the "Intended Electronics Separation") by way of a spin-off transaction, thereby creating a new independent, publicly traded electronics company ("ElectronicsCo"). The Intended Electronics Separation will not require a shareholder vote and is subjec ...

Envista (NVST) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants Jim Gustafson - VP - IRPaul Keel - CEOEric Hammes - Chief Financial OfficerJonathan Block - Managing Director Conference Call Participants Jason Bednar - Senior Research AnalystElizabeth Anderson - Senior Managing Director & Research AnalystJeffrey Johnson - Managing Director, Senior Research AnalystAllen Lutz - Senior Equity Research AnalystSteven Valiquette - MD & Senior Equity Research Analyst - Covering Health Care Techno ...

Envista (NVST) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants Jim Gustafson - VP - IRPaul Keel - CEOEric Hammes - Chief Financial OfficerJonathan Block - Managing Director Conference Call Participants Jason Bednar - Senior Research AnalystElizabeth Anderson - Senior Managing Director & Research AnalystJeffrey Johnson - Managing Director, Senior Research AnalystAllen Lutz - Senior Equity Research AnalystSteven Valiquette - MD & Senior Equity Research Analyst - Covering Health Care Techno ...

Traeger (COOK) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Company Participants Nick Bacchus - VP of IR, Treasury & Capital marketsJeremy Andrus - CEODominic Blosil - Chief Financial OfficerSabrina Baxamusa - Equity Research Associate Conference Call Participants Anna Glaessgen - Senior Research AnalystPeter Benedict - Senior Research AnalystBrian McNamara - MD & Senior Analyst - ConsumerNone - Analyst Operator Good afternoon. Thank you for attending the Traeger First Quarter Fiscal twenty twenty five Ea ...

Traeger (COOK) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 Good Speaker1 afternoon. Thank you for attending the Traeger First Quarter Fiscal twenty twenty five Earnings Conference Call. My name is Matt, and I'll be the moderator for today's call. All lines will be muted in the presentation portion of the call for an opportunity for questions and answers at the end. I'll now have to pass the conference over to our host, Nick Backus with Traeger. Nick, please go ahead. Speaker2 Good afternoon, eve ...

KeyBanc Capital Markets analyst Noah Zatzkin reiterated a Sector Weight rating on Garmin Ltd GRMN on Wednesday.Garmin reported on Wednesday first-quarter 2025 revenue growth of 11% to $1.54 billion, beating the analyst consensus estimate of $1.50 billion. The GPS navigation and wearable technology company’s adjusted EPS of $1.61 missed the consensus estimate of $1.67. Also Read: Garmin Q4 Earnings: Wearables and Adventure Watches Drive Growth, 20% Dividend Hike, Stock SoarsGarmin now expects fiscal 2025 rev ...

Financial Data and Key Metrics Changes - First quarter sales from continuing operations grew 5% on both a reported and operational basis, totaling $2.63 billion, exceeding previous guidance of 3% to 4% [6][12] - Adjusted earnings per share from continuing operations were $0.55, up 53% compared to the prior year, driven by favorable top line results and lower non-operational expenses [27][33] - Adjusted gross margin from continuing operations was 41.8%, a decrease of 160 basis points year-over-year, impacted by higher planning and fulfillment costs [29] Business Line Data and Key Metrics Changes - Medical Products and Therapies (MPT) segment sales were $1.3 billion, increasing 6%, with strong growth in U.S. Infusion systems [13][14] - Healthcare Systems and Technologies (HST) segment sales totaled $704 million, increasing 6%, driven by 14% growth in the U.S. for Care and Connectivity Solutions [18][19] - Pharmaceutical segment sales were $581 million, increasing 3%, with injectables and anesthesia sales growing 4% [22] Market Data and Key Metrics Changes - The U.S. market showed strong recovery with hospitals beginning to rebuild inventory levels, particularly in IV Solutions, which is expected to improve as allocations are removed [16][62] - International procurement remains a part of operations, with ongoing impacts from U.S. and retaliatory tariffs affecting the supply chain [39][40] Company Strategy and Development Direction - The company is focused on leveraging its verticalized operating model to enhance agility and drive profitable growth [5] - Continued investments in innovation are prioritized to bring new products to market and redefine healthcare delivery [26] - The search for a permanent CEO is active, with the board working with a leading search firm to identify the right candidate [9] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the volatility in the global macro environment and the uncertainty created by new tariffs, but remains positive about opportunities for sales growth and margin expansion [8][34] - The company expects total sales growth of 7% to 8% on a reported basis for the full year 2025, with operational growth of 4% to 5% [35][42] Other Important Information - The company is actively working on mitigating the impacts of tariffs, including optimizing supply chains and seeking exemptions [40] - Adjusted operating margin from continuing operations is expected to be between 16% to 16.5% for the full year [41] Q&A Session Summary Question: What actions are being taken to offset tariff headwinds? - Management is optimizing supply chains, negotiating with suppliers, and seeking exemptions while maintaining targeted pricing strategies [47][48] Question: How should we think about the sustainability of the HST business recovery? - The HST segment has shown strong order growth and competitive wins, with management optimistic about its future performance despite monitoring the capital environment [52][56] Question: What is the expected impact of IV Solutions on the business as hospitals return to normal inventory levels? - Hospitals are expected to continue conservation efforts, but some are using more solutions than pre-hurricane levels, indicating a mixed recovery [60][62] Question: Can you provide clarity on the potential impact of pharmaceutical tariffs? - The company is monitoring the situation closely, with a small exposure from the Clarus plant, and is proactive in scenario planning [66] Question: What are the expectations for operating margin expansion in 2026? - Management remains committed to margin expansion, but acknowledges that the tariff environment will influence future projections [100][102]

The Hershey Company (HSY) Q1 2025 Earnings Call May 01, 2025 08:30 AM ET Speaker0 Greetings, and welcome to The Hershey Company First Quarter twenty twenty five Question and Answer Session. At this time, all participants are in a listen only mode. As a reminder, this conference is being recorded. I'd now like to turn the call over to your host, Anori Naughton, Senior Director of Investor Relations for The Hershey Company. Thank you. You may begin. Speaker1 Thank you, and good morning, everyone. Thank you fo ...

Teleflex (TFX) Q1 2025 Earnings Call May 01, 2025 08:00 AM ET Company Participants Lawrence Keusch - Vice President of Investor Relations & Strategy DevelopmentLiam Kelly - Chairman, President & CEOJohn Deren - EVP & CFOPatrick Wood - Managing DirectorJayson Bedford - Managing Director - Medical TechnologyAnthony Petrone - Managing DirectorRichard Newitter - Managing Director Conference Call Participants Michael Sarcone - AnalystVikramjeet Chopra - AnalystMatthew O'Brien - AnalystShagun Singh Chadha - Analy ...

Hamilton Beach Brands Company (HBB) Q1 2025 Earnings Call April 30, 2025 04:30 PM ET Speaker0 Thank you for standing by. At this time, I would like to welcome everyone to today's Hamilton Beach Brands First Quarter twenty twenty five Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a Q and A session. So without further ado, I would like to turn the call over to Brendan Frey, partner with ICR. Brendan, you have the floor. ...